Enter your login e-mail to the account
Search
Search parameters
Search results
- Use of biological treatment in oncology
MUDr. Michal Mego, MUDr. Lucia Masárová
(6/2011, Review articles )
- The significance of cerebrospinal fluid cytology for diagnosing tumors of the nervous system
doc. MUDr. Pavel Štourač, Ph.D., MUDr. Jana Bednářová, Ph.D., MUDr. Zdeňka Čermáková
(5/2009, Main topic ) - Neurologické projevy systémových maligních nádorů
MUDr. Igor Nestrašil
(1/2005, Main topic ) - Chronic subdural haematoma associated with advanced malignant tumor
prof. MUDr. Markéta Hermanová, Ph.D., MUDr. Dušan Hrabovský, doc. MUDr. Radim Jančálek, Ph.D., MUDr. Petr Burkoň, Ph.D., doc. MUDr. Jan Chrastina, Ph.D.
(2/2016, Case reports )
- ACTUAL MEDICATION OF THE BONE METASTASE
MUDr. Ivan Kolombo, FEBU, MUDr. Martina Poršová, MUDr. Jaroslav Porš, MUDr. Richard Pabišta
(5-6/2007, Review articles )
- Systemic treatment of metastatic triple negative breast cancer
MUDr. Emília Fatkulinová
(5/2018, Review articles ) - Systemic therapy of bone metastases
MUDr. Andrea Škripeková
(4/2012, Main topic ) - Publikujeme v zahraničí
redakcia
(4/2018, Information & comments ) - Publikujeme v zahraničí
(6/2014, Information & comments ) - Publikujeme v zahraničí
doc. MUDr. Michal Mego, PhD.
(4/2012, Information & comments ) - The pathologist´s contribution for a targeted biological therapy of neoplastic disorders
prof. MUDr. Lukáš Plank, CSc.
(1/2011, Review articles ) - The growth factors in oncology
MUDr. Ján Gyárfáš
(4/2012, Main topic ) - SPRÁVA Z 30. SAN ANTONIO BREAST CANCER SYMPOSIUM, 13. – 16. DECEMBER 2007
MUDr. Vladimír Malec
(1/2008, Review articles ) - Capecitabine and its role in the treatment of advanced HER2 positive breast cancer
doc. MUDr. Igor Andrašina, CSc., MUDr. Radovan Barilla, PhD.
(1/2011, Review articles ) - Radium 223Ra in the treatment of bone malignancies
prof. MUDr. Ján Kliment, CSc., MUDr. Hubert Poláček, Ph.D., doc. MUDr. Ivan Režňák, CSc.
(5/2016, Review articles ) - ESMO BREAST CANCER COURSE: prvýkrát na Slovensku
doc. MUDr. Mária Wagnerová, CSc.
(1/2006, Events ) - Anti-tumor therapy in patients with liver insufficiency
MUDr. Michal Mego, PhD., MUDr. Ján Rajec, PhD.
(1/2011, Review articles ) - Current options in the treatment of HER2 low metastatic breast cancer
MUDr. Radovan Barila, PhD.
(2/2024, Review articles ) - Publikujeme v zahraničí
(3/2013, Information & comments ) - Publikujeme v zahraničí
(1/2011, Information & comments ) - Publikujeme v zahraničí
(5/2016, Information & comments ) - CARDIOVASCULAR COMPLICATIONS OF SELECTED ANTICANCER AGENTS – NEW INSIGHTS INTO PATHOGENESIS AND DIAGNOSTICS
doc. MUDr. Beáta Mladosievičová, CSc., MUDr. Silvia Cingelová
(2/2008, Review articles ) - Novinky z ASCO 2006
MUDr. Tomáš Šálek, MUDr. Radovan Barilla,
(3/2006, Events ) - Current recommendations for bisphosphonates therapy in cancer patients
prof. MUDr. Stanislav Špánik, CSc., MUDr. Beata Špániková, PhD.
(6/2013, Review articles ) - Primary breast lymphoma – rewiev and case reports
MUDr. Miriam Ladická
(1/2009, Original articles & case reports ) - Treatment of HR+, HER2- advanced/metastatic breast cancer according to ESO-ESMO recommendations ABC 5
MUDr. Soňa Johnová, MUDr. Soňa Huľová
(2/2021, Review articles ) - Late effects of anticancer therapy
MUDr. Mária Rečková, Prof. MUDr. Beata Mladosievičová, CSc.
(3/2015, Main topic ) - Anthracyclines in treating metastatic breast cancer
MUDr. Katarína Petráková
(3/2014, Review articles ) - Follow-up after treatment in patients with malignant disease
MUDr. Branislav Bystrický, MUDr. Filip Kohútek, MUDr. Andrej Rosík, MUDr. Miroslava Stratená, MUDr. Mário Bôžik
(3/2015, Main topic ) - Publikujeme v zahraničí
(6/2013, Information & comments ) - Publikujeme v zahraničí
(3/2014, Information & comments ) - Management of adverse reactions in treatment with mTOR and CDK4/6 inhibitors
MUDr. Branislav Bystrický, PhD., MPH
(2/2019, Review articles ) - Gastrointestinal toxicity, hepatotoxicity and nephrotoxicity of targeted treatment
MUDr. Branislav Bystrický, MUDr. Alexandra Szabová
(1/2013, Main topic ) - LHRH analogs in treatment of breast cancer
MUDr. Ján Rajec, PhD., MUDr. Lucia Dzurillová
(3/2015, Review articles ) - Radionavigated sentinel node detection in carcinomas of the oral cavity
doc. MUDr. Izabela Makaiová, CSc., MUDr. Patrik Štefanička, PhD., MUDr. Boris Duchaj, MUDr. Jaroslav Veselý, PharmDr. Klára Aksamitová, Ing. Soňa Skrašková, RNDr. Soňa Kováčová, CSc.
(2/2010, Original articles & case reports ) - Current position of vinorelbine within complex breast cancer treatment
MUDr. Silvia Jurišová, MUDr. Miroslava Malejčíková
(6/2016, Drugs & drug classes ) - Treatment of patients with HR+, HER2- PIK3CA-mutated advanced/metastatic breast cancer: results of trial SOLAR-1
MUDr. Andrej Rosík
(2/2021, Review articles ) - Novinky zo San Antonio Breast Cancer Symposium
prof. MUDr. Stanislav Špánik, CSc., MUDr. Vladimír Malec, PhD., MUDr. Mária Rečková
(1/2013, Events ) - Importance of immunohistochemistry and application of TTF-1 and napsin A in differential diagnosis of primary pulmonary adenocarcinomas and pulmonary metastases of extrapulmonary origins
MUDr. Adela Mikuľaková, MUDr. Zuzana Hríbiková
(2/2017, Review articles ) - Publikujeme v zahraničí
(6/2015, Information & comments ) - Cardiotoxicity of targeted cancer therapy
doc. MUDr. Beáta Mladosievičová, CSc., MUDr. Mária Rečková
(1/2013, Main topic ) - Publikujeme v zahraničí
(2/2012, Information & comments ) - Ipilimumab in the treatment of malignant melanoma
MUDr. Róbert Godál
(3/2011, Drugs & drug classes ) - Publikujeme v zahraničí
(3/2011, Information & comments ) - Specifics of treatment of breast cancers in women older than 70 years
doc. MUDr. Mária Wagnerová, CSc.
(5/2012, Main topic ) - Biological therapy in geriatric patients
doc. MUDr. Michal Mego, PhD.
(5/2012, Main topic ) - Position of 4/6 cyclin-dependent kinase inhibitors in the 1st line of treatment of metastatic breast cancer
MUDr. Katarína Krajcsovics, PhD.
(4/2019, Review articles ) - Nano-particle nab-paclitaxel in treatment of metastatic breast cancer
MUDr. Jozef Dolinský, MUDr. Radovan Barilla, PhD.
(4/2011, Review articles ) - Publikujeme v zahraničí
(5/2011, Information & comments ) - New mechanism of action in the treatment of renal cell carcinoma: m-TOR – a novel target
MUDr. Hana Študentová, prof. MUDr. Bohuslav Melichar, Ph.D.
(5/2010, Review articles ) - Diagnosis of the cancer of unknown primary origin
MUDr. Štefan Pörsök, PhD., MUDr. Silvia Jurišová
(4/2013, Main topic ) - Therapeutic procedures in the treatment of advanced triple-negative breast cancer – a nationwide survey among selected oncologists from oncology institutes and regional cancer centers in Slovakia
MUDr. Radovan Barila, PhD., MUDr. Elena Marušáková, MBA, Ing. Jan Žigmond
(3/2024, Review articles ) - Nab-technologies, nab-paclitaxel and new treatment possibilities in the treatment of selected oncology diseases
MUDr. Tomáš Šálek, MUDr. Radovan Barilla, PhD.
(4/2014, Review articles ) - Správy z podujatia ASCO Chicago 2014
prof. MUDr. Stanislav Špánik, CSc., MUDr. Mária Rečková, MUDr. Patrik Palacka, PhD. MPH, MBA
(4/2014, Events ) - Publikujeme v zahraničí
(4/2013, Information & comments ) - Nové perspektívy v liečbe pokročilého a metastatického HR+ HER2- karcinómu prsníka
MUDr. Miroslava Malejčíková, MUDr. Silvia Jurišová
(2/2018, Review articles ) - New research and therapeutic targets in molecular genetics of tumors − our research potential
RNDr. Alena Gábelová, CSc., Mgr. Miroslav Chovanec, PhD., RNDr. Ján Sedlák, DrSc., Mgr. Lucia Kučerová, PhD., RNDr. Božena Smolková, PhD., Mgr. Viera Kajabová, PhD., RNDr. Ivana Fridrichová, CSc.
(1/2015, Main topic ) - Použitie rastových faktorov myelopoézy v profylaxii febrilnej neutropénie
MUDr. Juraj Chudej, PhD., MUDr. Matej Hrnčár, MUDr. Juraj Sokol, PhD., MUDr. Ivana Plameňová, PhD., MUDr. Ľubica Váleková, PhD., Prof. MUDr. Ján Staško, PhD.
(2/2018, Review articles ) - Dual inhibition after failure of NSAI as a solution to hormone therapy resistance
MUDr. Bibiána Vertáková Krakovská, PhD.
(1/2015, Review articles ) - Breast cancers in erderly women
doc. MUDr. Mária Wagnerová, CSc., doc. MUDr. Alexander Berč, CSc.
(2/2009, Review articles ) - Zriedkavé epitelové nádory prsníka
MUDr. Mária Rečková, PhD.
(3/2018, Main topic ) - Eribulin in treatment of breast cancer
doc. MUDr. Mária Wagnerová, CSc., MUDr. Hana Garanová
(1/2015, Drugs & drug classes ) - A comprehensive view of the treatment of HER2-positive breast cancer
MUDr. Bela Mriňáková, PhD., MPH
(2/2022, Main topic ) - The role of PARP inhibitors in the treatment of breast cancer
MUDr. Eliška Volochová, MUDr. Marián Streško, PhD.
(2/2022, Main topic ) - Micrometastases in sentinel node of breast carcinoma
MUDr. Marián Karaba, MUDr. Juraj Benca, MUDr. Róbert Duchoň
(2/2009, Original articles & case reports ) - Publikujeme v zahraničí
(1/2015, Information & comments ) - How do we look at CDK4/6 inhibitors in palliative treatment today
MUDr. Miroslava Malejčíková
(2/2022, Main topic ) - Odporúčania Slovenskej onkologickej spoločnosti SLS pre použitie bisfosfonátov v liečbe solídnych nádorov
prof. MUDr. Stanislav Špánik, CSc.
(4/2009, Recommendations ) - Publikujeme v zahraničí
(4/2015, Information & comments ) - The role of epigenetic regulation in epithelial-to-mesenchymal transition
Mgr. Lucia Svoreňová, Mgr. Božena Smolková, PhD.
(6/2017, Review articles ) - Advances in the treatment of triple- negative breast cancer
MUDr. Lea Balážová, doc. MUDr. Igor Andrašina, CSc.
(5/2022, Review articles ) - THE INTRODUCTION TO INTERPRETATION OF CLINICAL TRIALS – Part II.
MUDr. Michal Mego, PhD., MUDr. Mária Rečková
(3/2008, Review articles ) - Importance of immunohistochemistry in the differential diagnosis of gestational trophoblastic disease
prof. MUDr. Ľudovít Danihel, PhD., MUDr. Michal Palkovič, PhD., MUDr. Zuzana Čierna, MUDr. Kristína Kuracinová, doc. MUDr. Miroslav Korbeľ, CSc., MUDr. Ľudovít Danihel, ml.
(5/2014, Main topic ) - The efect of CDK 4/6 inhibition on overal survival in metastatic breast cancer
MUDr. Bibiána Vertáková Krakovská, PhD.
(2/2020, Review articles ) - Radiotherapy of bone metastases
doc. MUDr. Pavol Dubinský, PhD.
(5/2013, Main topic ) - Publikujeme v zahraničí
doc. MUDr. Michal Mego, PhD.
(3/2012, Information & comments ) - Targeted terapy of gastric cancer
MUDr. Vanda Ušáková, PhD.
(5/2014, Review articles ) - Publikujeme v zahraničí
(5/2014, Information & comments ) - Publikujeme v zahraničí
(4/2016, Information & comments ) - Publikujeme v zahraničí
(1/2012, Information & comments ) - Kam posunul trastuzumab deruxtecan liečbu HER2+ pozitívneho karcinómu prsníka?
MUDr. Miroslava Malejčíková
(2/2023, Review articles ) - ABC transporters: multidrug resistance and different types of human diseases
prof. MUDr. Stanislav Špánik, CSc., doc. MUDr. Viera Lehotská, PhD., MUDr. Katarína Rauová, RNDr. Eva Weismanová, PhD., RNDr. Ľubomír Horváth, CSc., Mgr. Ján Markus, PhD., MUDr. Ladislav Sopko
(1/2012, Review articles ) - Exosomes – new topic in diagnostics of cancer
RNDr. Ján Sedlák, DrSc., Mgr. Martina Zdurienčíková, RNDr. Paulína Gronesová, PhD., RNDr. Dana Cholujová, PhD., RNDr. Ľuba Hunáková, CSc.
(5/2015, Review articles ) - A case of a patient developed an acute coronary syndrome during the treatment with Bevacizumab
MUDr. Mária Rečková, Prof. MUDr. Beata Mladosievičová, CSc., MUDr. Barbora Piteková
(5/2015, Original articles & case reports ) - Lorlatinib in 1st line ALK-positive non-small cell lung cancer
MUDr. Lucia Denková
(4/2024, Drugs & drug classes ) - Skeletal metastases
MUDr. Beata Špániková, PhD., MUDr. Lucia Vanovčanová, PhD., MUDr. Martin Kaško, PhD., prof. MUDr. Stanislav Špánik, CSc., MHA
(5/2023, Review articles ) - Publikujeme v zahraničí
(5/2015, Information & comments ) - Publikujeme v zahraničí
(1/2016, Information & comments ) - Monoclonal antibodies in antitumorous therapy and infectious complications
MUDr. Ľuboš Drgoňa, CSc.
(6/2010, Review articles ) - Some Aspects of Venous Thromboembolism in Patients with Solid Tumours
MUDr. Katarína Dostálová, MUDr. Patrik Palacka, PhD.
(6/2010, Review articles ) - Circulating and disseminated tumor cells
MUDr. Michal Mego, PhD.
(6/2010, Review articles ) - PARP inhibitors
prof. MUDr. Stanislav Špánik, CSc.
(6/2010, Review articles ) - Publikujeme v zahraničí
(2/2015, Information & comments ) - Faslodex 500 and new treatment options
MUDr. Katarína Petráková
(6/2010, Drugs & drug classes ) - ESMO 2010 – kongres, ktorý prelomil rekordy
doc. MUDr. Peter Beržinec, CSc.
(6/2010, Events ) - Novinky z American Society of Clinical Oncology 2010
doc. MUDr. Peter Beržinec, CSc., MUDr. Tomáš Šálek, prof. MUDr. Stanislav Špánik, CSc., MUDr. Mária Rečková
(4/2010, Events ) - Publikujeme v zahraničí
doc. MUDr. Michal Mego, PhD.
(6/2012, Information & comments ) - Ribociclib, inhibitor of cyclin-dependent kinases 4 and 6, in the treatment of HR+/HER2 - advanced breast cancer
MUDr. Mária Rečková
(1/2017, Drugs & drug classes ) - Palbociclib in the treatment of advanced breast cancer
MUDr. Branislav Bystrický
(1/2017, Drugs & drug classes ) - Abemaciclib in first-line treatment of HR+, HER2- breast cancer with visceral metastases in a premenopausal patient
MUDr. Soňa Johnová, MUDr. Soňa Huľová
(3/2022, Case reports ) - DID THE INTRODUCTION OF TARGETED THERAPY LIMIT THE IMPORTANCE OF CYTOSTATIC TREATMENT ?
prof. MUDr. Pavel Klener, DrSc.
(6/2007, Review articles ) - RECENT CLASSIFICATION AND MORPHOLOGICAL CHARACTERISTICS OF TROPHOBLASTIC NEOPLASMS
prof. MUDr. Ľudovít Danihel, PhD., MUDr. Vladimír Šišovský, PhD., MUDr. Michal Palkovič, PhD., MUDr. Andrea Černá, PhD.
(4/2008, Review articles ) - Adjuvant hormonal therapy of postmenopausal breast cancer patients
prof. MUDr. Stanislav Špánik, CSc.
(3/2009, Review articles ) - Metronomic chemotherapy in breast cancer
MUDr. Bibiána Vertáková Krakovská, PhD.
(1/2018, Review articles ) - Principles of hormonal therapy and chemotherapy in the treatment of metastatic HR+, HER2- breast cancer
MUDr. Miroslava Malejčíková
(6/2018, Review articles ) - Experience with exemestane in daily practise
MUDr. Jana Obertová, MUDr. Ivana Zigová
(3/2009, Original articles & case reports ) - CONTEMPORARY POSSIBILITY OF THE TREATMENT OF BONE METASTASES
prof. MUDr. Ľudovít Jurga, CSc.
(3/2007, Review articles - treatment ) - IMPORTANCE OF IMMUNOHISTOCHEMICAL EXAMINATION IN DETECTING METASTASES IN SENTINEL LYMPH NODES IN BREAST CANCER WOMEN
MUDr. Karel Šťastný, MUDr. Vladimír Červinka, MUDr. Lukáš Nechvátal, prof. MUDr. Arnošt Pellant, DrSc., prof. MUDr. Aleš Ryška, PhD.
(4/2008, Original articles ) - SEKCAMA 2009
MUDr. Vladimír Bella, PhD., MUDr. Dušan Malatin
(3/2009, Events ) - „Therapeutic“ mesenchymal stem cells in the treatment of oncological patients – truth or error?
MUDr. Ján Lakota, CSc., prof. MUDr. Stanislav Špánik, CSc.
(1/2018, Information & comments ) - Zaujímavosti z literatúry
doc. MUDr. Peter Beržinec, CSc.
(3/2009, Information & comments ) - SOME ASPECTS OF ADJUVANT TREATMENT OF COLORECTAL CANCER
MUDr. Zuzana Hlavatá
(4/2008, Review articles ) - Molecular classification of liposarcomas
RNDr. Katarína Hlinková
(6/2011, Review articles )
- Hidradenoma – case report of rare adnexal tumor of skin
MUDr. Vladimír Bartoš, MUDr. Oľga Zacharová
(2/2011, Original articles & case reports ) - Acne-like rash and another skin toxicities associated with administration of HER1/EGFR inhibitors
MUDr. Katarína Poláková, PhD.
(1/2010, Review articles )
- Skeletal metastatic disease: how to confirm and to proceed in the search for primary tumor
MUDr. Kristina Križanová, MUDr. Andrea Škripeková
(2e/2015, Review articles ) - The use of biologic therapy in the prevention of pain and complications of osseal metastases in cancer diseases
MUDr. Kristina Križanová
(2/2013, Original articles )
- Some Aspects of Venous Thromboembolism in Patients with Solid Tumours
MUDr. Katarína Dostálová, MUDr. Patrik Palacka, PhD.
(3/2011, Review articles ) - The prophylaxis of venous thromboembolism and metastatic breast cancer
prof. MUDr. Peter Kubisz, DrSc., MUDr. Juraj Chudej, PhD., MUDr. Branislav Bystrický, MUDr. Filip Kohútek, MUDr. Matej Hrnčár, MUDr. Juraj Sokol, PhD., MUDr. Andrej Rosík
(2/2016, Original articles & Case reports )
- Stem cells in surgery
MUDr. Martina Fialová, MUDr. Ivan Brychta, PhD.
(2/2012, Review articles )